This weeks CotW is from our recent webinar. This figure demonstrates the results of an analysis focused on identifying biomarkers that are measured together frequently in clinical trials. The goal of the analysis was to identify groups of biomarkers that are linked by both co-occurrence in trials, and also by shared functional attributes. These biomarkers are all measured together in at least three recent clinical trials, and the size of the line connecting each biomarker pair indicates the total number of trials in which each pair is measured (i.e thicker = more trials). The biomarkers are also color-coded based on shared biological functions.
Share this Image On Your Site
<p><strong>Please include attribution to amplion.com with this graphic.</strong><br /><br /><a href=’http://www.amplion.com/biomarker-trends/chart-of-the-week-panel-opportunities-in-lung-cancer’><img src=’https://www.amplion.com/wp-content/uploads/2016/05/Screen_Shot_2016-05-03_at_11.42.16_AM.png’ alt=’Biomarker co-occurance in lung cancer’ width=’540px’ border=’0′ /></a></p>